Cargando…

CARS Imaging Advances Early Diagnosis of Cardiac Manifestation of Fabry Disease

Vibrational spectroscopy can detect characteristic biomolecular signatures and thus has the potential to support diagnostics. Fabry disease (FD) is a lipid disorder disease that leads to accumulations of globotriaosylceramide in different organs, including the heart, which is particularly critical f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tolstik, Elen, Ali, Nairveen, Guo, Shuxia, Ebersbach, Paul, Möllmann, Dorothe, Arias-Loza, Paula, Dierks, Johann, Schuler, Irina, Freier, Erik, Debus, Jörg, Baba, Hideo A., Nordbeck, Peter, Bocklitz, Thomas, Lorenz, Kristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142043/ https://www.ncbi.nlm.nih.gov/pubmed/35628155 http://dx.doi.org/10.3390/ijms23105345

Ejemplares similares

Discrimination between pathogenic and non-pathogenic E. coli strains by means of Raman microspectroscopy
por: Lorenz, Björn, et al.
Publicado: (2020)

Chemical fingerprinting of single glandular trichomes of Cannabis sativa by Coherent anti-Stokes Raman scattering (CARS) microscopy
por: Ebersbach, Paul, et al.
Publicado: (2018)

FLIM data analysis based on Laguerre polynomial decomposition and machine-learning
por: Guo, Shuxia, et al.
Publicado: (2021)

Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y
por: Oder, Daniel, et al.
Publicado: (2016)

Hot topics in Fabry disease
por: Cairns, Tereza, et al.
Publicado: (2018)

Vibrational Spectroscopic Investigation of Blood Plasma and Serum by Drop Coating Deposition for Clinical Application
por: Huang, Jing, et al.
Publicado: (2021)

Validation of Blood Volume Fraction Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Porcine Skeletal Muscle
por: Hindel, Stefan, et al.
Publicado: (2017)

WE-ASCA: The Weighted-Effect ASCA for Analyzing Unbalanced Multifactorial Designs—A Raman Spectra-Based Example
por: Ali, Nairveen, et al.
Publicado: (2020)

Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real‐World Data”
por: Müntze, Jonas, et al.
Publicado: (2019)

X‐chromosomal inactivation patterns in women with Fabry disease
por: Wagenhäuser, Laura, et al.
Publicado: (2022)

Circulating microRNAs in Fabry Disease
por: Xiao, Ke, et al.
Publicado: (2019)

Ophthalmic Manifestations in Fabry Disease: Updated Review
por: Gambini, Gloria, et al.
Publicado: (2023)

Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy
por: Müntze, Jonas, et al.
Publicado: (2018)

Gene variants of unknown significance in Fabry disease: Clinical characteristics of c.376A>G (p.Ser126Gly)
por: Lau, Kolja, et al.
Publicado: (2022)

Renal Manifestations of Fabry Disease: A Narrative Review
por: Silva, Cassiano Augusto Braga, et al.
Publicado: (2021)

Current status of cardiac manifestations in Fabry disease and their treatment
por: Radulescu, Dan, et al.
Publicado: (2021)

Fabry disease – a multisystemic disease with gastrointestinal manifestations
por: Lenders, Malte, et al.
Publicado: (2022)

Characterization of vertigo and hearing loss in patients with Fabry disease
por: Köping, Maria, et al.
Publicado: (2018)

Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year
por: Müntze, Jonas, et al.
Publicado: (2019)

Exploring the Steps of Infrared (IR) Spectral Analysis: Pre-Processing, (Classical) Data Modelling, and Deep Learning
por: Mokari, Azadeh, et al.
Publicado: (2023)

Intranuclear inclusions in hepatocellular carcinoma contain autophagy‐associated proteins and correlate with prolonged survival
por: Schwertheim, Suzan, et al.
Publicado: (2019)

High Variability of Fabry Disease Manifestations in an Extended Italian Family
por: Cammarata, Giuseppe, et al.
Publicado: (2015)

Cardiac manifestations in patients with classical or cardiac subtype of Fabry disease
por: Wang, Wei-Ting, et al.
Publicado: (2020)

Ocular manifestations in a patient with de novo Fabry disease
por: Lee, You Hyun, et al.
Publicado: (2018)

Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease
por: Köping, Maria, et al.
Publicado: (2017)

Right ventricular pressure overload directly affects left ventricular torsion mechanics in patients with precapillary pulmonary hypertension
por: Kaiser, Ralf, et al.
Publicado: (2020)

Protective Effects of Thyroid Hormone Deprivation on Progression of Maladaptive Cardiac Hypertrophy and Heart Failure
por: Kerp, Helena, et al.
Publicado: (2021)

Longitudinal study on ocular manifestations in a cohort of patients with Fabry disease
por: Michaud, Langis
Publicado: (2019)

Optical Sectioning and High Resolution in Single-Slice Structured Illumination Microscopy by Thick Slice Blind-SIM Reconstruction
por: Jost, Aurélie, et al.
Publicado: (2015)

Case report of a 45-year old female Fabry disease patient carrying two alpha-galactosidase A gene mutation alleles
por: Oder, Daniel, et al.
Publicado: (2016)

Value of the CHA(2)DS(2)-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation
por: Liu, Dan, et al.
Publicado: (2018)

Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease
por: Liu, Dan, et al.
Publicado: (2018)

Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease
por: Miller, James J., et al.
Publicado: (2019)

Severe manifestations and treatment of COVID-19 in a transplanted patient with Fabry disease
por: Mahoney, Ryan, et al.
Publicado: (2021)

Autophagy-lysosome pathway alteration in ocular surface manifestations in Fabry disease patients
por: Marenco, Marco, et al.
Publicado: (2022)

High‐Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease
por: Seydelmann, Nora, et al.
Publicado: (2016)

Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors
por: Ali, Nairveen, et al.
Publicado: (2021)

A Novel Frameshift Mutation of Galactosidase-alpha in Fabry Disease Restricted to Dermatologic Manifestations
por: Kim, Dae Hun, et al.
Publicado: (2013)

The role of native T1 values on the evaluation of cardiac manifestation in Japanese Fabry disease patients
por: Anan, Ikuko, et al.
Publicado: (2022)

Gastrointestinal Manifestations and Low-FODMAP Protocol in a Cohort of Fabry Disease Adult Patients
por: Gugelmo, Giorgia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uvsgom0tenni99a1m5157lb8l5